The influence of lipophilicity on the antibacterial activity of rifamycins.
D001419:Bacteria / Q000187:drug effects* / Q000378:metabolism; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011514:Proteus vulgaris / Q000187:drug effects; D012044:Regression Analysis; D012293:Rifampin / Q000494:pharmacology; D012294:Rifamycins / Q000494:pharmacology*; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D012294:Rifamycins; D012293:Rifampin